Immunome
IMNM
29 hedge funds and large institutions have $10.2M invested in Immunome in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 4 closing their positions.
47% more call options, than puts
Call options by funds: $240K | Put options by funds: $163K
0.8% less ownership
Funds ownership: 23.07% → 22.27% (-0.8%)
3% less funds holding
Funds holding: 30 → 29 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
72% less capital invested
Capital invested by funds: $36.4M → $10.2M (-$26.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIM
Baldwin Investment Management
West Conshohocken,
Pennsylvania
|
+$190K |
| 2 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$114K |
| 3 |
AGM
Alpine Global Management
New York
|
+$113K |
| 4 |
Renaissance Technologies
New York
|
+$105K |
| 5 |
State Street
Boston,
Massachusetts
|
+$19.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$486K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$237K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$159K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$138K |
| 5 |
PCM
Prentice Capital Management
Greenwich,
Connecticut
|
-$106K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $1K | -$17.7K | -2,371 | -95% |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $1K | -$5.94K | -794 | -86% |
|
|
BIM
28
Baldwin Investment Management
West Conshohocken,
Pennsylvania
| $144 | +$190K | +25,394 | New |
|
|
29
Citadel Advisors
Miami,
Florida
| – | -$159K | -21,216 | Closed |
|
|
30
Marshall Wace
London,
United Kingdom
| – | -$138K | -10,654 | Closed |
|
31
Bank of America
Charlotte,
North Carolina
| – | -$81K | -6,244 | Closed |
|
32
Simplex Trading
Chicago,
Illinois
| – | -$45.5K | -6,086 | Closed |
|
IMNM Hedge Fund Activity: Q1 2022 in Review
29 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Immunome (IMNM) for Q1 2022, worth a combined $10.2M — down 72% from $36.4M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of IMNM and 3 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 6 added.
The largest buyer was Baldwin Investment Management, opening a new position worth an estimated $190K. The largest seller was Morgan Stanley, cutting an estimated $486K.
- 29 institutional investors held Immunome (IMNM) as of Q1 2022, down from 30 in Q4 2021.
- Funds reported $10.2M of Immunome stock for Q1 2022, down 72% quarter-over-quarter.
- 3 funds opened new Immunome positions in Q1 2022 and 4 closed out, a net change of -1 holder.
- The largest Immunome buyer in Q1 2022 was Baldwin Investment Management, an estimated $190K added.
- The largest Immunome seller in Q1 2022 was Morgan Stanley, an estimated $486K sold.
Based on aggregated 13F filings for Q1 2022.